Skip to main content
Equibles

Legal & General Group Plc

Position in ADCT — ADC Therapeutics SA

CIK 764068 London, X0
Back to ADCT Full portfolio

Position in ADCT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$9,642
-$24,153 QoQ
Shares Held
9,012
0.0% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#87
of 113 holders
Holding Since
Jun 2020
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ADCT Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Legal & General Group Plc holds $776,969,626 across 46 Drug Manufacturers - Specialty & Generic names. ADCT ranks #44 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 3,567,388 $256,352,500
2 TEVA
Teva Pharmaceutical Industries Ltd
 3,916,666 $132,696,643
3 UTHR
UNITED THERAPEUTICS Corp
 207,093 $112,209,199
4 VTRS
Viatris Inc
 4,069,647 $64,625,993
5 NBIX
Neurocrine Biosciences Inc
 314,451 $52,997,570
6 ALKS
Alkermes plc.
 393,524 $20,620,657
7 ELAN
Elanco Animal Health Inc
 711,233 $17,503,443
8 XERS
Xeris Biopharma Holdings, Inc.
 2,012,792 $15,941,311

All Filings in ADCT

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,642 9,012
2026-03-31 $33,795 9,012
2025-12-31 $31,501 8,924
2025-09-30 $32,340 8,085
2025-06-30 $21,667 8,085
2025-03-31 $12,037 8,537
2024-12-31 $16,988 8,537
2024-09-30 $26,891 8,537
2024-06-30 $22,388 7,085
2020-06-30 $117,025 2,500